On October 6, 2020 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that the company plans to present at the following conferences (Press release, Iovance Biotherapeutics, OCT 6, 2020, View Source [SID1234568156]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Cell Therapy Summit (VIRTUAL) | October 6, 2020
Date/Time: Tuesday, Oct. 6 at 3:00 p.m. EDT
Webcast: a live and archived webcast of the presentation will be available in the Investors section of the Iovance website at View Source
Alliance for Regenerative Medicine (ARM) Meeting on the Mesa (VIRTUAL) | October 12-16, 2020
Date/Time: presentation available on demand beginning Oct. 12, 2020, at View Source
A live and archived webcast of the presentation will be available in the Investors section of the Iovance website at View Source.